Knockdown of FTO markedly reduced tumor volume and tumor growth in both Mel624 and CHL-1 cells in immunocompromised nude mice, and in B16F10 cells in immunocompetent C57BL/6 mice (Fig. 2f, g, and Supplementary Fig. 2a–j). This evidence concerns the gene FTO and neoplasm.